Lam Research Corporation $LRCX is Heard Capital LLC’s 7th Largest Position

Heard Capital LLC reduced its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 8.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,752,190 shares of the semiconductor company’s stock after selling 153,915 shares during the quarter. Lam Research makes up approximately 8.9% of Heard Capital LLC’s portfolio, making the stock its 7th largest position. Heard Capital LLC owned about 0.14% of Lam Research worth $170,558,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. ICONIQ Capital LLC boosted its stake in shares of Lam Research by 3.1% during the 2nd quarter. ICONIQ Capital LLC now owns 12,426 shares of the semiconductor company’s stock valued at $1,210,000 after buying an additional 374 shares during the period. IHT Wealth Management LLC purchased a new stake in shares of Lam Research during the second quarter worth $2,320,000. George Kaiser Family Foundation raised its holdings in shares of Lam Research by 54.2% during the second quarter. George Kaiser Family Foundation now owns 5,514 shares of the semiconductor company’s stock worth $537,000 after acquiring an additional 1,939 shares in the last quarter. EP Wealth Advisors LLC boosted its position in Lam Research by 9.2% during the second quarter. EP Wealth Advisors LLC now owns 46,721 shares of the semiconductor company’s stock valued at $4,548,000 after purchasing an additional 3,922 shares during the last quarter. Finally, Eventide Asset Management LLC grew its stake in Lam Research by 35.2% in the second quarter. Eventide Asset Management LLC now owns 996,897 shares of the semiconductor company’s stock valued at $97,281,000 after purchasing an additional 259,702 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Price Performance

NASDAQ LRCX opened at $160.52 on Friday. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $169.69. The company has a fifty day simple moving average of $152.53 and a 200 day simple moving average of $119.99. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The company has a market cap of $201.62 billion, a P/E ratio of 35.36, a P/E/G ratio of 1.73 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same quarter in the previous year, the business earned $0.86 EPS. The business’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, sell-side analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.6%. Lam Research’s dividend payout ratio is presently 22.91%.

Insiders Place Their Bets

In other news, insider Ava Harter sold 9,010 shares of the stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the sale, the insider directly owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. This represents a 13.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of the business’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 102,608 shares of company stock worth $14,916,496. Corporate insiders own 0.31% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. UBS Group reaffirmed a “buy” rating and set a $175.00 price target (up from $165.00) on shares of Lam Research in a research note on Tuesday, November 25th. Mizuho increased their price objective on Lam Research from $162.00 to $170.00 and gave the stock an “outperform” rating in a report on Thursday, October 23rd. TD Cowen raised their price objective on shares of Lam Research from $145.00 to $170.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Zacks Research cut shares of Lam Research from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 24th. Finally, Cowen restated a “buy” rating on shares of Lam Research in a research note on Thursday, October 23rd. Twenty-six research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat, Lam Research currently has a consensus rating of “Moderate Buy” and a consensus target price of $152.87.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.